dronabinol (Marinol)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Marinol. DEA-controlled substance: class 3. (delta-9-tetrahydrocannabinol)

Indications

Dosage

Tabs: 2.5, 5, 10 mg.

Pharmacokinetics

elimination via liver

1/2life = 25-36 hours

protein binding = 94-99 %

Adverse effects

Drug interactions

Laboratory

Mechanism of action

More general terms

Component of

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  3. Clinical Guide to Laboratory Tests, 3rd ed. Teitz ed., W.B. Saunders, 1995
  4. Jump up to: 4.0 4.1 Prescriber's Letter 12(6):32 2005 New Drug: Sativex (Delta-9-tetrahydrocannabinol and Cannabidiol) Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=210605&pb=PRL (subscription needed) http://www.prescribersletter.com
  5. Jump up to: 5.0 5.1 Associated Press Oct 6, 2006
  6. Jump up to: 6.0 6.1 HIGHLIGHTS OF PRESCRIBING INFORMATION MARINOL (dronabinol) capsules, for oral use, CIII https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018651s029lbl.pdf

Database